TcrossGlobal

TAVR vs. drug therapy in patients with non-severe aortic stenosis and reduced LVEF

In patients with non-severe low pressure gradient aortic stenosis (LGAS) and LVEF <50%, treatment with TAVR was associated with significantly higher 2-year and cardiovascular survival rates compared with medical therapy, and TAVR was an independent predictor of survival. Dr. Sebastian Ludwig, University Heart and Vascular Center Hamburg, Germany, reported in the May issue of Circulation: Cardiovascular Interventions.

Dr. Ludwig et al. included 706 patients with <50% LVEF who underwent TAVR by femoral artery appro...

Continue reading this article

Select an option below:

Free Registration
Already have an account?
Log In

Introducing the main contents

Conference Reports

Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!

Complex PCI Cases

Features case reports on patients with complex lesions encountered in daily clinical practice.

Live Demonstration CoursesComing soon

In this section you will find live videos of catheter interventions for complex lesions.

What is TCROSS NEWS GLOBAL?

TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.

Learn more about TCROSS NEWS Global

This website is automatically translated using Google Translate.